KR20050044451A - 기생충 방제용 벤즈이미다졸- 또는인돌-아미노아세토니트릴 유도체 - Google Patents

기생충 방제용 벤즈이미다졸- 또는인돌-아미노아세토니트릴 유도체 Download PDF

Info

Publication number
KR20050044451A
KR20050044451A KR1020047007293A KR20047007293A KR20050044451A KR 20050044451 A KR20050044451 A KR 20050044451A KR 1020047007293 A KR1020047007293 A KR 1020047007293A KR 20047007293 A KR20047007293 A KR 20047007293A KR 20050044451 A KR20050044451 A KR 20050044451A
Authority
KR
South Korea
Prior art keywords
halo
alkyl
alkoxy
unsubstituted
alkylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020047007293A
Other languages
English (en)
Korean (ko)
Inventor
피에르 두끄레이
토마스 괴벨
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20050044451A publication Critical patent/KR20050044451A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
KR1020047007293A 2001-11-14 2002-11-13 기생충 방제용 벤즈이미다졸- 또는인돌-아미노아세토니트릴 유도체 Withdrawn KR20050044451A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2103/01 2001-11-14
CH21032001 2001-11-14

Publications (1)

Publication Number Publication Date
KR20050044451A true KR20050044451A (ko) 2005-05-12

Family

ID=4567523

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047007293A Withdrawn KR20050044451A (ko) 2001-11-14 2002-11-13 기생충 방제용 벤즈이미다졸- 또는인돌-아미노아세토니트릴 유도체

Country Status (16)

Country Link
US (1) US7279495B2 (enExample)
EP (1) EP1446386A1 (enExample)
JP (1) JP2005518351A (enExample)
KR (1) KR20050044451A (enExample)
CN (1) CN1304378C (enExample)
AR (1) AR037363A1 (enExample)
AU (1) AU2002351995B2 (enExample)
BR (1) BR0214151A (enExample)
CA (1) CA2466971A1 (enExample)
CO (1) CO5390082A1 (enExample)
MX (1) MXPA04004605A (enExample)
NZ (1) NZ532864A (enExample)
RU (1) RU2004118247A (enExample)
TW (1) TW200300140A (enExample)
WO (1) WO2003042184A1 (enExample)
ZA (1) ZA200403459B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042420A1 (es) 2002-09-11 2005-06-22 Novartis Ag Benzotriazolil- aminoacetonitril compuestos, proceso para su preparacion, metodo y uso de los mismos en el control de endo- y ecto-parasitos dentro y sobre ganado productor de sangre caliente y animales domesticos y plantas, y en la preparacion de una composicion farmaceutica
US20040192738A1 (en) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
GB0402677D0 (en) * 2003-11-06 2004-03-10 Novartis Ag Organic compounds
WO2006043654A1 (ja) * 2004-10-22 2006-04-27 Nihon Nohyaku Co., Ltd. アセトニトリル誘導体及び有害生物防除剤並びにその使用方法
KR20080033298A (ko) * 2005-07-12 2008-04-16 바이엘 크롭사이언스 소시에떼아노님 벤조헤테로시클릴에틸카르복사미드 유도체
TWI387592B (zh) 2005-08-30 2013-03-01 Novartis Ag 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法
KR101472649B1 (ko) 2007-05-15 2014-12-16 메리얼 리미티드 아릴로아졸-2-일 시아노에틸아미노 화합물, 이의 제조방법 및 이의 사용방법
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
WO2010048191A1 (en) 2008-10-21 2010-04-29 Merial Limited Thioamide compounds, method of making and method of using thereof
RS58508B1 (sr) 2008-11-14 2019-04-30 Merial Inc Enantiomerno obogaćena paraziticidalna jedinjenja ariloazol-2-il cijanoetilamino
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
MX345971B (es) * 2012-04-20 2017-02-28 Merial Ltd Composiciones parasiticidas que comprenden derivados de benzimidazol, metodos y usos de los mismos.
US8822689B2 (en) 2012-09-19 2014-09-02 Merial Limited Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
WO2015170753A1 (ja) * 2014-05-08 2015-11-12 国立大学法人大阪大学 熱対流生成用チップ及び液体秤量具
ES2723969T3 (es) 2014-06-19 2019-09-04 Merial Inc Composiciones parasiticidas que comprenden derivados de indol, procedimientos y usos de las mismas
EP3980414A1 (en) 2019-06-07 2022-04-13 Elanco Tiergesundheit AG Bicyclic derivatives for treating endoparasites

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239077B1 (en) * 1998-05-01 2001-05-29 Nihon Nohyaku Co., Ltd. Aminoacetonitrile derivative agricultural and horticultural insecticide containing the same and use thereof

Also Published As

Publication number Publication date
CN1304378C (zh) 2007-03-14
EP1446386A1 (en) 2004-08-18
AR037363A1 (es) 2004-11-03
WO2003042184A1 (en) 2003-05-22
ZA200403459B (en) 2006-11-29
US20050026972A1 (en) 2005-02-03
MXPA04004605A (es) 2005-03-07
CA2466971A1 (en) 2003-05-22
US7279495B2 (en) 2007-10-09
CO5390082A1 (es) 2004-04-30
RU2004118247A (ru) 2006-01-10
TW200300140A (en) 2003-05-16
JP2005518351A (ja) 2005-06-23
BR0214151A (pt) 2004-09-14
AU2002351995B2 (en) 2006-08-10
CN1599725A (zh) 2005-03-23
NZ532864A (en) 2005-11-25

Similar Documents

Publication Publication Date Title
EP1539719B1 (en) Benzotriazol-1-ylamino-acetonitrile compounds and the use thereof in pest control
US7279495B2 (en) Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
KR100644976B1 (ko) 특정 구충 활성을 갖는 인다졸-아미노아세토니트릴 유도체
AU2002351995A1 (en) Benzimidazol-or indol-aminoacetonitrile derivatives for parasite control
KR100648117B1 (ko) 아미노아세토니트릴 유도체 및 기생충을 방제하기 위한그의 용도
KR100687678B1 (ko) N-아실아미노아세토니트릴 유도체 및 기생충을 방제하기위한 그의 용도
US7521476B2 (en) Aminoacetonitrile derivatives suitable for controlling parasites
KR100675718B1 (ko) 유기 화합물
KR100651111B1 (ko) 아미도아세토니트릴 유도체
KR100679200B1 (ko) 아미도아세토니트릴 화합물 및 살충제로서의 그의 용도
KR100628842B1 (ko) 벤즈아미도아세토니트릴 및 이의 항기생충제로서의 용도

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040513

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid